We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 10,000 results
  1. Medial flap middle turbinoplasty for solid middle turbinate hypertrophy: improving airway, speeding healing and preserving olfaction

    Purpose

    The techniques to be performed for bullous middle turbinates are well-defined and widely accepted in the literature. However, in the case of...

    Abdullah Ozdem, Orhan Ozturan, ... Erol Senturk in European Archives of Oto-Rhino-Laryngology
    Article 16 October 2023
  2. Hot melt emulsification shear method for solid lipid-based suspension: from laboratory-scale to pilot-scale production

    The clinical application of solid lipid particles (SLPs) is hampered due to the need for advanced nano/micro-suspension production technology. This...

    Chao Li, Wenqing **e, ... Shuyu **e in Animal Diseases
    Article Open access 27 October 2023
  3. Evolving or immutable - phase I solid tumor trials in the era of precision oncology

    In the era of precision oncology (PO), systemic therapies for patients (pts) with solid tumors have shifted from chemotherapy (CT) to targeted...

    Shannon S. Stockton, G. Dan Ayers, ... Jordan Berlin in Investigational New Drugs
    Article Open access 22 May 2024
  4. Prehabilitation in Adult Solid Organ Transplant Candidates

    Purpose of Review

    To highlight the importance of biological age in the context of prehabilitation and to present relevant research regarding...

    Evelien E. Quint, Manoela Ferreira, ... Robert A. Pol in Current Transplantation Reports
    Article Open access 25 March 2023
  5. The Relationship Between Spiritual Well-Being and Post-Traumatic Growth in Turkish Patients Undergoing Solid Organ Transplantation

    This study was conducted to determine the relationship between spiritual well-being and post-traumatic growth in solid organ transplant patients....

    Emine Selda Gündüz, Dilek Avci, Nihal Kiraz in Journal of Religion and Health
    Article 17 August 2023
  6. Efficacy and predictive factors of endoscopic ultrasound-guided ethanol ablation in benign solid pancreatic tumors

    Backgrounds and Objectives

    Endoscopic ultrasound-guided ethanol ablation (EUS-EA) has recently been introduced for the management of solid pancreatic...

    ** Ho Choi, Woo Hyun Paik, ... Yong-Tae Kim in Surgical Endoscopy
    Article Open access 20 April 2023
  7. ICU admission for solid cancer patients treated with immune checkpoint inhibitors

    Background

    Immune checkpoint inhibitors (ICI) have revolutionized the management of cancer. They can induce immune-related adverse events (irAE)...

    Anne-Claire Toffart, Anne-Pascale Meert, ... Virginie Lemiale in Annals of Intensive Care
    Article Open access 18 April 2023
  8. Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours

    Background

    Ezabenlimab (BI 754091) is a humanised monoclonal antibody targeting programmed cell death protein-1. We report results from open-label,...

    Manish R. Patel, Melissa Johnson, ... Lillian L. Siu in Cancer Immunology, Immunotherapy
    Article Open access 30 March 2024
  9. Investigation of mediastinal lymph node dissection in clinical stage IA pure-solid non-small cell lung cancer patients

    Objective

    To explore the independent predictors of pathological mediastinal lymph node (pN2) metastasis in clinical stage IA (cIA) pure-solid...

    Jianlong Bu, Sainan Pang, ... Changfa Qu in Journal of Cardiothoracic Surgery
    Article Open access 24 June 2024
  10. Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan

    Background

    Comprehensive genomic profiling (CGP) can aid the discovery of clinically useful, candidate antitumor agents; however, the variant...

    Tatsuro Yamaguchi, Masachika Ikegami, ... Hideyuki Ishida in International Journal of Clinical Oncology
    Article 25 May 2024
  11. New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors

    Purpose of Review

    This review will describe the various applications, benefits, risks, and approaches of conventional irreversible electroporation...

    Jung H. Yun, Adam Fang, ... Nariman Nezami in Current Oncology Reports
    Article 11 September 2023
  12. Sophisticated genetically engineered macrophages, CAR-Macs, in hitting the bull’s eye for solid cancer immunotherapy approaches

    Studies have begun to employ macrophages engineered with chimeric antigen receptor (CAR-Macs) against solid tumors since they can enter solid tumor...

    Article 06 June 2023
  13. Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends

    Immune-checkpoint inhibitors (ICBs), in addition to targeting CTLA-4, PD-1, and PD-L1, novel targeting LAG-3 drugs have also been approved in...

    Qian Sun, Zhenya Hong, ... Ding Ma in Signal Transduction and Targeted Therapy
    Article Open access 28 August 2023
  14. Management of ground-glass opacities and sub-solid pulmonary nodules: a surgeon’s perspective

    The regular use of high-resolution computed tomogram scans has led to an increase in the detection of asymptomatic ground-glass opacities and...

    Kaushalendra Rathore, Mark Newman in Indian Journal of Thoracic and Cardiovascular Surgery
    Article 02 February 2023
  15. Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors

    Purpose

    Treatment decisions for leptomeningeal disease (LMD) rely on patient risk stratification, since clinicians lack objective prognostic tools....

    Andrew B. Barbour, Barbara Blouw, ... Jonathan T. Yang in Journal of Neuro-Oncology
    Article 05 March 2024
  16. A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor

    Background

    Recurrent or refractory solid and central nervous system (CNS) tumours in paediatric patients have limited treatment options and carry a...

    Louise Evans, Rick Walker, ... David S. Ziegler in Targeted Oncology
    Article Open access 28 March 2024
  17. A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies

    Background

    Phosphatase of regenerating liver-3 (PRL-3) is involved in cellular processes driving metastasis, cell proliferation, invasion, motility...

    Cheng E. Chee, Melissa Ooi, ... Boon-Cher Goh in Targeted Oncology
    Article Open access 15 April 2023
  18. Household air pollution from solid fuel use and depression among adults in rural China: evidence from the China Kadoorie Biobank data

    Background

    Solid fuels are still widely used for cooking in rural China, leading to various health implications. Yet, studies on household air...

    Sek Ying Chair, Kai Chow Choi, ... Wai Tong Chien in BMC Public Health
    Article Open access 06 June 2023
  19. Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

    Therapies with genetically modified T cells that express chimeric antigen receptors (CARs) specific for CD19 or B cell maturation antigen (BCMA) are...

    Christian L. Flugel, Robbie G. Majzner, ... Mohamed Abou-el-Enein in Nature Reviews Clinical Oncology
    Article 23 November 2022
  20. Intraductal papilloma with atypical ductal hyperplasia and neuroendocrine differentiation as a possible precursor lesion of solid papillary carcinoma

    Breast papillary neoplasms include a wide range of tumor types, and their pathological diagnosis is sometimes difficult. Furthermore, the etiology of...

    Yutaro Mihara, Rin Yamaguchi, ... Hirohisa Yano in Medical Molecular Morphology
    Article 07 June 2023
Did you find what you were looking for? Share feedback.